Well Advised The Need for Counseling in Early Stages of Alzheimer's Disease

被引:4
作者
Perry, Julia [1 ]
Brose, Julia [1 ]
Radenbach, Katrin [2 ,3 ]
机构
[1] Univ Med Ctr Gottingen, Dept Med Eth & Hist Med, Gottingen, Germany
[2] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany
[3] Univ Med Ctr, Dept Psychiat & Psychotherapy, Von Siebold Str 5, D-37075 Gottingen, Germany
关键词
cognitive impairment; Alzheimer's disease; counseling; affected individuals; ethics; BIOMARKERS; DIAGNOSIS; BETA;
D O I
10.1024/1662-9647/a000318
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Societal and scientific interest in the prediction and early diagnosis of Alzheimer's disease is growing. However, decisions regarding early diagnosis must be well-considered. The decision-making process requires specific counseling for concerned individuals, which is currently missing. In our project "Well Advised", we investigate the needs and expectations of people concerned about their memory regarding counseling services in Germany. Using a mixed-methods approach, we analyze the evaluative interviews from telephone counseling (n = 44) and one expert focus group with 4 participants. Our evaluation shows a great need for information; the low-threshold telephone counseling service is appreciated. The topics of interest of those seeking advice concern medical-ethical issues of autonomy, the right (not) to know, and risk-benefit considerations. From these findings, we developed a training module and counseling guideline.
引用
收藏
页码:189 / 202
页数:14
相关论文
共 37 条
[1]  
Ad Hoc Working Group in the German Stakeholder Conference on Conflicts in Predictive Dementia Diagnostics, 2018, CONSENSUAL POSITION
[2]   Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed [J].
Alpinar-Sencan, Zuemruet ;
Schicktanz, Silke .
BMC MEDICAL ETHICS, 2020, 21 (01)
[3]   Sociology and Science: The Making of a Social Scientific Method [J].
Au, Anson .
AMERICAN SOCIOLOGIST, 2018, 49 (01) :98-115
[4]   Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey [J].
Bertens, Daniela ;
Vos, Stephanie ;
Kehoe, Patrick ;
Wolf, Henrike ;
Nobili, Flavio ;
Mendonca, Alexandre ;
van Rossum, Ineke ;
Hort, Jacub ;
Luis Molinuevo, Jose ;
Heneka, Michael ;
Petersen, Ron ;
Scheltens, Philip ;
Visser, Pieter Jelle .
ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)
[5]  
Bingham A.J., 2022, Analyzing and interpreting qualitative data: After the interview, P133
[6]   Alzheimer's disease [J].
Scheltens, Philip ;
De Strooper, Bart ;
Kivipelto, Miia ;
Holstege, Henne ;
Chetelat, Gael ;
Teunissen, Charlotte E. ;
Cummings, Jeffrey ;
van der Flier, Wiesje M. .
LANCET, 2021, 397 (10284) :1577-1590
[7]  
Boyatzis RichardE., 1998, Transforming Qualitative Information
[8]   The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey [J].
Caprioglio, Camilla ;
Garibotto, Valentina ;
Jessen, Frank ;
Froelich, Lutz ;
Allali, Gilles ;
Assal, Frederic ;
Frisoni, Giovanni B. ;
Altomare, Daniele .
JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (02) :535-551
[9]  
Deutsche Gesellschaft fur Psychiatrie und Psycho- therapie Psychosomatik und Nervenheilkunde (DGPPN) Deutsche Gesellschaft fur Neurologie, 2016, S3-Leitlinie Demenzen
[10]   Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society [J].
Erickson, Claire M. ;
Clark, Lindsay R. ;
Ketchum, Fred B. ;
Chin, Nathaniel A. ;
Gleason, Carey E. ;
Largent, Emily A. .
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)